Ivermectin -Gastroenterologist Professor Thomas Borody
Gastroenterologist Professor Thomas Borody says Ivermectin used in conjunction with two other drugs is making it look like “corona is very simple to kill”.
Ivermectin in Peru
ugust 14, 2020
TrialSite News productions introduces a new documentary special about Peru, COVID-19, and the acceptance of Ivermectin as a formally approved treatment for the novel coronavirus. Filmed right in Peru by a Peruvian film crew contracted by TrialSite, the documentary was commissioned to help other parts of the world better understand why Peru and the surrounding region have become an epicenter for a community physician movement that advocated for the off-label use of Ivermectin to treat COVID-19 patients. Many doctors there in the South American nation swear by it. In fact, some of them cursed the government for not embracing it sooner while other doctors are vehemently opposed to the use of the anti-parasitic drug for COVID-19—at least until there is more actual evidence of its efficacy. Watch this original TrialSite production to learn how Ivermectin became popular in Peru as an Ivermectin treatment. What is the basis and justification for its use? Have formal clinical trials been undertaken there? Why are many physicians fervently pro-use while others adamantly opposed? What is going on with self-treatment and why does that represent trouble in Peru? What is the path forward for Ivermectin as a COVID-19 treatment in Peru? This South American country might just portend the future for other low-to-middle-income countries as they seek pragmatic ways to battle the novel coronavirus.
Ivermectin Breaking into American News as Doctors Come Forward
Dr. Lauren Mickey, an ears, eyes and throat specialist at Glenwood Medical Mall in West Monroe, Louisiana, was recently interviewed by local television station Fox 14, reporting that the cheap and widely available medication Ivermectin is being used at this provider’s practice—successfully treating COVID-19 patients, reports the news station.
Originally developed for animals and then decades ago developed for humans as an anti-parasite “Wonder Drug,” TrialSite has chronicled this medication’s usage against COVID-19 around the world as well as in the United States off label. Now in West Monroe, Louisiana, this Otolaryngology Specialist has come forward to share that although Hydroxychloroquine had been considered a potential drug, and it may have some impact on COVID-19, the Louisiana-based doctors suggests that Ivermectin actually attacks COVID-19.
The Monash Report
TrialSite first reported on the Ivermectin breakthrough based on lab research driven by Monash University and Peter Doherty Institute in Australia: the team found that Ivermectin in certain amounts kills SARS-CoV-2, the virus behind COVID-19, in a cell culture environment. That report led to community-level physician experimentation around the world, in some cases accumulating so-called real world evidence as to the safety and efficacy of the drug. Over three dozen clinical trials have been launched as well, including a couple in the United States. A couple studies have produced positive results although 1) the studies didn’t have a lot of patients, and 2) the studies were based in low-to middle-income countries (LMICs). Peru is one nation that has allowed Ivermectin on the national clinical therapy list in association with COVID-19.
The Broward County Real World Data
The use of Ivermectin has been limited thus far in the United States, although the curiosity has grown since the observational study out of Broward Health led by Dr. Jean-Jacques Rajter, a physician who treated hundreds of patients successfully with the antiparasitic drug.
More from West Monroe LA
Robert Mitchell, MD
Octobe 21, 2020
27,802 views
•Jul 2, 2020
Dr. Mobeen Sayed and Adam Gaertner
